Dewpoint Therapeutics, Inc. research brief
CIK 1828893
Generated Nov. 18, 2026, 12:48 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: BOSTON Massachusetts. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- July 13, 2026 · D/A · 0001828893-26-000001 · Source evidence
Reported offering amount: 82299400 USD. Reported amount sold: 77164102 USD.
- Sept. 23, 2025 · D · 0001828893-25-000002 · Source evidence
Reported offering amount: 59124298 USD. Reported amount sold: 59124298 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Dewpoint Therapeutics, Inc. research brief,” CIK 1828893, retrieved Nov. 18, 2026, 12:48 p.m.. Cite the specific accessions used. No amounts have been summed.